163 related articles for article (PubMed ID: 23625595)
21. Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.
Naguib A; Cooke JC; Happerfield L; Kerr L; Gay LJ; Luben RN; Ball RY; Mitrou PN; McTaggart A; Arends MJ
BMC Cancer; 2011 Apr; 11():123. PubMed ID: 21473780
[TBL] [Abstract][Full Text] [Related]
22. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.
Beckham TH; Cheng JC; Lu P; Marrison ST; Norris JS; Liu X
PLoS One; 2013; 8(10):e76593. PubMed ID: 24098536
[TBL] [Abstract][Full Text] [Related]
23. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
Arber N; Hibshoosh H; Moss SF; Sutter T; Zhang Y; Begg M; Wang S; Weinstein IB; Holt PR
Gastroenterology; 1996 Mar; 110(3):669-74. PubMed ID: 8608874
[TBL] [Abstract][Full Text] [Related]
25. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
26. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
Arvai KJ; Hsu YH; Lee LA; Jones D
PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
[TBL] [Abstract][Full Text] [Related]
27. Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas.
Lin WR; Chiang JM; Lim SN; Su MY; Chen TH; Huang SW; Chen CW; Wu RC; Tsai CL; Lin YH; Alison MR; Hsieh SY; Yu JS; Chiu CT; Yeh CT
EBioMedicine; 2019 Jun; 44():334-345. PubMed ID: 31122841
[TBL] [Abstract][Full Text] [Related]
28. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
Shao J; Washington MK; Saxena R; Sheng H
Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
[TBL] [Abstract][Full Text] [Related]
30. Expression and localization of apolipoprotein M in human colorectal tissues.
Luo G; Zhang X; Mu Q; Chen L; Zheng L; Wei J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2010 Sep; 9():102. PubMed ID: 20846402
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of mTOR and p-mTOR protein expression in human colorectal carcinomas.
Wang D; Chen J; Guo F; Chen H; Duan Z; Wei MY; Xu QM; Wang LH; Zhong MZ
Asian Pac J Cancer Prev; 2011; 12(10):2581-4. PubMed ID: 22320958
[TBL] [Abstract][Full Text] [Related]
32. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
[TBL] [Abstract][Full Text] [Related]
33. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
34.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
35. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
Li Q; Yang Z
J Exp Clin Cancer Res; 2009 May; 28(1):65. PubMed ID: 19445727
[TBL] [Abstract][Full Text] [Related]
36. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps.
Lauwers GY; Wahl SJ; Melamed J; Rojas-Corona RR
Am J Gastroenterol; 1993 Nov; 88(11):1916-9. PubMed ID: 8237942
[TBL] [Abstract][Full Text] [Related]
37. Importance of serrated polyps in colorectal carcinogenesis.
Liang JJ; Bissett I; Kalady M; Bennet A; Church JM
ANZ J Surg; 2013 May; 83(5):325-30. PubMed ID: 23078414
[TBL] [Abstract][Full Text] [Related]
38. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
39. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.
Balbinotti RA; Ribeiro U; Sakai P; Safatle-Ribeiro AV; Balbinotti SS; Scapulatempo C; Alves VA; Corbett CE; Carrilho FJ
Anticancer Res; 2007; 27(6C):4465-71. PubMed ID: 18214062
[TBL] [Abstract][Full Text] [Related]
40. PTEN expression and mutation in colorectal carcinomas.
Li XH; Zheng HC; Takahashi H; Masuda S; Yang XH; Takano Y
Oncol Rep; 2009 Oct; 22(4):757-64. PubMed ID: 19724853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
